Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongyang Zhao

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Frontiers in Cellular and Infection Microbiology|June 19, 2024
Clinical evaluation of droplet digital PCR in the early identification of suspected sepsis patients in the emergency department: a prospective observational studySen Jiang, Dongyang Zhao, Chunxue Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 22, 2025
UFMylation of NLRP3 Prevents Its Autophagic Degradation and Facilitates Inflammasome ActivationJiongjie Jing, Fan Yang, Ke Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 11, 2017
Enhancing the Quantum Anomalous Hall Effect by Magnetic Codoping in a Topological InsulatorYunbo Ou, Chang Liu, Gaoyuan Jiang, et al.
Ebiomedicine|March 9, 2023
Cytotoxic CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cells contribute to the pathogenesis of systemic lupus erythematosusHui Xiong, Mintian Cui, Ni Kong, et al.
Vaccine|March 22, 2024
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and olderYuhui Zhang, Yanxia Wang, Guangfu Li, et al.
Vaccines|May 7, 2025
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialYan Liu, Guangwei Feng, Jinyuan Wu, et al.
JAMA|August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsShengli Xia, Kai Duan, Yuntao Zhang, et al.
Frontiers in Immunology|July 11, 2022
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 TrialShengli Xia, Kai Duan, Yuntao Zhang, et al.
Eclinicalmedicine|July 12, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trialWanshen Guo, Kai Duan, Yuntao Zhang, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Frontiers in Cellular and Infection Microbiology|June 19, 2024
Clinical evaluation of droplet digital PCR in the early identification of suspected sepsis patients in the emergency department: a prospective observational studySen Jiang, Dongyang Zhao, Chunxue Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 22, 2025
UFMylation of NLRP3 Prevents Its Autophagic Degradation and Facilitates Inflammasome ActivationJiongjie Jing, Fan Yang, Ke Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 11, 2017
Enhancing the Quantum Anomalous Hall Effect by Magnetic Codoping in a Topological InsulatorYunbo Ou, Chang Liu, Gaoyuan Jiang, et al.
Ebiomedicine|March 9, 2023
Cytotoxic CD161<sup>-</sup>CD8<sup>+</sup> T<sub>EMRA</sub> cells contribute to the pathogenesis of systemic lupus erythematosusHui Xiong, Mintian Cui, Ni Kong, et al.
Vaccine|March 22, 2024
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and olderYuhui Zhang, Yanxia Wang, Guangfu Li, et al.
Vaccines|May 7, 2025
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialYan Liu, Guangwei Feng, Jinyuan Wu, et al.
JAMA|August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsShengli Xia, Kai Duan, Yuntao Zhang, et al.
Frontiers in Immunology|July 11, 2022
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 TrialShengli Xia, Kai Duan, Yuntao Zhang, et al.
Eclinicalmedicine|July 12, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trialWanshen Guo, Kai Duan, Yuntao Zhang, et al.
Pageof 9